[1] |
McManus DP,, Bergquist R,, Cai PF, et al. Schistosomiasis-from immunopathology to vaccines[J]. Semin Immunopathol, 2020, 42(3): 355-371.
doi: 10.1007/s00281-020-00789-x
pmid: 32076812
|
[2] |
Zhang LJ,, Xu ZM,, Yang F, et al. Endemic status of schistosomiasis in People’s Republic of China in 2020[J]. Chin J Schisto Control, 2021, 33(3): 225-233. (in Chinese)
|
|
(张利娟,, 徐志敏,, 杨帆, 等. 2020年全国血吸虫病疫情通报[J]. 中国血吸虫病防治杂志, 2021, 33(3): 225-233.)
|
[3] |
Wang L,, Wang YH,, Quan J. Exosomes derived from natural killer cells inhibit hepatic stellate cell activation and liver fibrosis[J]. Hum Cell, 2020, 33(3): 582-589.
doi: 10.1007/s13577-020-00371-5
|
[4] |
van Eeden C,, Khan L,, Osman MS, et al. Natural killer cell dysfunction and its role in COVID-19[J]. Int J Mol Sci, 2020, 21(17): 6351.
doi: 10.3390/ijms21176351
|
[5] |
Wijaya RS,, Read SA,, Schibeci S, et al. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B[J]. J Hepatol, 2019, 71(2): 252-264.
doi: S0168-8278(19)30182-5
pmid: 30905683
|
[6] |
Yi HS,, Lee YS,, Byun JS, et al. Alcohol dehydrogenase Ⅲ exacerbates liver fibrosis by enhancing stellate cell activation and suppressing natural killer cells in mice[J]. Hepatology, 2014, 60(3): 1044-1053.
doi: 10.1002/hep.27137
|
[7] |
Fan YT,, Zhang WD,, Wei HM, et al. Hepatic NK cells attenuate fibrosis progression of non-alcoholic steatohepatitis in dependent of CXCL10-mediated recruitment[J]. Liver Int, 2020, 40(3): 598-608.
doi: 10.1111/liv.14307
|
[8] |
Hou X,, Yu FZ,, Man SQ, et al. Negative regulation of Schistosoma japonicum egg-induced liver fibrosis by natural killer cells[J]. PLoS Negl Trop Dis, 2012, 6(1): e1456.
doi: 10.1371/journal.pntd.0001456
|
[9] |
Villesen IF,, Daniels SJ,, Leeming DJ, et al. Review article: the signalling and functional role of the extracellular matrix in the development of liver fibrosis[J]. Aliment Pharmacol Ther, 2020, 52(1): 85-97.
doi: 10.1111/apt.15773
|
[10] |
Jiang PY,, Pan WQ. Advances in liver fibrosis and pathogenesis of schistosomiasis[J]. Chin Trop Med, 2018, 18(8): 847-852. (in Chinese)
|
|
(姜鹏月,, 潘卫庆. 血吸虫病肝纤维化及其致病机制研究进展[J]. 中国热带医学, 2018, 18(8): 847-852.)
|
[11] |
Hu Y,, Wang XL,, Wei YH, et al. Functional inhibition of natural killer cells in a BALB/c mouse model of liver fibrosis induced by Schistosoma japonicum infection[J]. Front Cell Infect Microbiol, 2020, 10: 598987.
doi: 10.3389/fcimb.2020.598987
|
[12] |
Terrén I,, Orrantia A,, Vitallé J, et al. NK cell metabolism and tumor microenvironment[J]. Front Immunol, 2019, 10: 2278.
doi: 10.3389/fimmu.2019.02278
pmid: 31616440
|
[13] |
Becker PSA,, Suck G,, Nowakowska P, et al. Selection and expansion of natural killer cells for NK cell-based immunotherapy[J]. Cancer Immunol Immunother, 2016, 65(4): 477-484.
doi: 10.1007/s00262-016-1792-y
pmid: 26810567
|
[14] |
Peng H,, Tian ZG. NK cells in liver homeostasis and viral hepatitis[J]. Sci China Life Sci, 2018, 61(12): 1477-1485.
doi: 10.1007/s11427-018-9407-2
pmid: 30421296
|
[15] |
Fasbender F,, Widera A,, Hengstler JG, et al. Natural killer cells and liver fibrosis[J]. Front Immunol, 2016, 7: 19.
doi: 10.3389/fimmu.2016.00019
pmid: 26858722
|
[16] |
Hayakawa Y,, Andrews DM,, Smyth MJ. Subset analysis of human and mouse mature NK cells[J]. Methods Mol Biol, 2010, 612: 27-38.
|
[17] |
Widowati W,, Jasaputra DK,, Sumitro SB, et al. Effect of interleukins (IL-2, IL-15, IL-18) on receptors activation and cytotoxic activity of natural killer cells in breast cancer cell[J]. Afr Health Sci, 2020, 20(2): 822-832.
doi: 10.4314/ahs.v20i2.36
pmid: 33163049
|
[18] |
Liu C,, Zhang YS,, Chen F, et al. Immunopathology in schistosomiasis is regulated by TLR2, 4- and IFN-γ-activated MSC through modulating Th1/Th2 responses[J]. Stem Cell Res Ther, 2020, 11(1): 217.
doi: 10.1186/s13287-020-01735-2
|
[19] |
Chester C,, Fritsch K,, Kohrt HE. Natural killer cell immunomodulation: targeting activating, inhibitory, and co-stimulatory receptor signaling for cancer immunotherapy[J]. Front Immunol, 2015, 6: 601.
doi: 10.3389/fimmu.2015.00601
pmid: 26697006
|
[20] |
Khomich O,, Ivanov AV,, Bartosch B. Metabolic hallmarks of hepatic stellate cells in liver fibrosis[J]. Cells, 2019, 9(1): 24.
doi: 10.3390/cells9010024
|
[21] |
Hamidzadeh K,, Christensen SM,, Dalby E, et al. Macrophages and the recovery from acute and chronic inflammation[J]. Annu Rev Physiol, 2017, 79: 567-592.
doi: 10.1146/annurev-physiol-022516-034348
pmid: 27959619
|
[22] |
Zhang YX,, Xiong DH,, Li YY, et al. Schistosoma japonicum infection in treg-specific USP21 knockout mice[J]. J Immunol Res, 2021, 2021: 6613162.
|
[23] |
Hammerich L,, Tacke F. Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis[J]. World J Gastrointest Pathophysiol, 2015, 6(3): 43-50.
doi: 10.4291/wjgp.v6.i3.43
pmid: 26301117
|
[24] |
Park HS,, Kim J,, Cho MY, et al. Effectual labeling of natural killer cells with upconverting nanoparticles by electroporation for in vivo tracking and biodistribution assessment[J]. ACS Appl Mater Interfaces, 2020, 12(44): 49362-49370.
doi: 10.1021/acsami.0c12849
|